Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

Recent & Breaking News (TSX:SZLS)

StageZero Life Sciences Announces Closing of Convertible Debenture Financing

Accesswire February 21, 2020

StageZero Life Sciences to participate in Mercer's new vendor database in the U.S.

Accesswire January 30, 2020

StageZero Life Sciences Announces Closing of Financing

Accesswire January 27, 2020

StageZero Life Sciences Retains Fig House Communications to Manage Investor Relations Activities

Accesswire January 13, 2020

StageZero Life Sciences Announces Conversion of December 2016 Convertible Debentures

Accesswire January 3, 2020

StageZero Life Sciences Adds BreastSentry and Prostate Health Index to Licensing and Services Agreement with Oncore Pharma

Accesswire December 9, 2019

StageZero Life Sciences Announces Q3 2019 Progress Update

Accesswire November 15, 2019

StageZero Life Sciences Expands Telehealth Presence With the Addition of New Partners Including an e-Commerce Platform and Expansion of In-Home Mobile Phlebotomy

Accesswire November 14, 2019

StageZero Announces 3rd Quarter 2019 Investor Call

Accesswire November 13, 2019

StageZero Life Sciences Makes ColonSentry(R) Blood Test Available to Consumers Through Online Telehealth Platform

Accesswire November 6, 2019

StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL: Update to Clarify Details Within the Agreement

Accesswire October 21, 2019

IIROC Trade Resumption - SZLS

Canada NewsWire October 10, 2019

StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL; Multi-Year Agreement Valued at US$40 million

Accesswire October 10, 2019

IIROC Trading Halt - SZLS

Canada NewsWire October 10, 2019

StageZero Life Sciences Direct to Consumer Marketing Campaign for Prostate Cancer Awareness Month Attracts Thousands of Responses

Accesswire October 2, 2019

StageZero Life Sciences to Present at the Fall Investor Summit on September 16th-17th in New York City

Accesswire September 12, 2019

StageZero Life Sciences Announces Q2 2019 Progress Update

Accesswire August 14, 2019

StageZero Announces 2nd Quarter 2019 Investor Call

Accesswire August 12, 2019

StageZero Life Sciences to Present at ii6 Summit in Toronto

Accesswire August 7, 2019

StageZero Life Sciences Announces Second Closing of CDN $3.7 Million Private Placement

Accesswire July 26, 2019